
May 2, 2019
VivaQuant, a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, has received FDA clearance for its RX-1 wearable device.
Read more →
Sign-up for the Weekly Newsletter from FDA Reporter.